This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Google Scholar Articles by Cavazzana, I Articles by Franceschini, F PubMed PubMed Citation Articles by Cavazzana, I Articles by Franceschini, F Social Bookmarking                   What's this?

Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases

Rheumatology Unit and Chair, Spedali Civili, Università degli Studi di Brescia, Brescia, Italy, ilariacava{at}virgilio.it

A Ceribelli

Rheumatology Unit and Chair, Spedali Civili, Università degli Studi di Brescia, Brescia, Italy

M Quinzanini

Rheumatology Unit and Chair, Spedali Civili, Università degli Studi di Brescia, Brescia, Italy

M Scarsi

Rheumatology Unit and Chair, Spedali Civili, Università degli Studi di Brescia, Brescia, Italy

P Airò

Rheumatology Unit and Chair, Spedali Civili, Università degli Studi di Brescia, Brescia, Italy

R Cattaneo

Rheumatology Unit and Chair, Spedali Civili, Università degli Studi di Brescia, Brescia, Italy

F Franceschini

Rheumatology Unit and Chair, Spedali Civili, Università degli Studi di Brescia, Brescia, Italy

We retrospectively analysed the prevalence and clinical features associated to anti-Ku antibodies in patients affected by different autoimmune diseases. Anti-Ku antibodies are detected in 147 sera out of 7239 anti-ENA positive sera (2%). They are found in 2% of patients with systemic sclerosis (SSc) (8 out of 379), 1.8% of systemic lupus erythematosus (SLE) (7 out of 372) and 1.8% of undifferentiated connective tissue disease (UCTD) (9 out of 496) and more rarely in Sjögren Syndrome and rheumatoid arthritis. Most of anti-Ku positive patients were affected by UCTD and overlap syndromes, including polymyositis, SSc and SLE. Interstitial lung disease, myositis, articular symptoms, Raynaud's phenomenon and sicca represents the main clinical features detected in our cohort. The rate and severity of pulmonary disease is similar to those found in other SSc patients. Isolated anti-Ku were detected in about 47% of sera. No clinical differences were observed between these patients and subjects with multiple anti-nuclear specificities. However, anti-Ku are usually detected in association with other serological markers in SLE and Sjögren Syndrome, while they occurred isolated in SSc and polymyositis.

Key Words: anti-ENA • anti-Ku antibodies • overlap syndromes • polymyositis • systemic sclerosis

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?